Identification and selective inhibition of four distinct soluble forms of cyclic nucleotide phosphodiesterase activity from kidney

This publication has 22 references indexed in Scilit:

• The use of selective inhibitors and computer modelling to evaluate the role of specific high affinity cyclic AMP phosphodiesterases in the hormonal regulation of hepatocyte intracellular cyclic AMP concentrations
  Cellular Signalling, 1990
• Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form
  Biochemical Pharmacology, 1989
• Specific antibodies and the selective inhibitor ICI 118233 demonstrate that the hormonally stimulated ‘dense-vesicle’ and peripheral-plasma-membrane cyclic AMP phosphodiesterases display distinct tissue distributions in the rat
  Biochemical Journal, 1987
• Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue
  Biochemical Pharmacology, 1987
• The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors
  Biochemical Journal, 1987
• Insulin, glucagon and the receptor-mediated control of cyclic AMP concentrations in liver
  Biochemical Society Transactions, 1986
• A New Generation of Phosphodiesterase Inhibitors: Multiple Molecular Forms of Phosphodiesterase and the Potential for Drug Selectivity
  Journal of Medicinal Chemistry, 1985
• Positive Inotropic Agents
  Annual Review of Pharmacology and Toxicology, 1984
• Agents for the treatment of heart failure
  Medicinal Research Reviews, 1983
• Identification and properties of cyclic nucleotide phosphodiesterases
  Molecular and Cellular Endocrinology, 1982